Effects of diarylpentanoid analogues of curcumin on chemiluminescence and chemotactic activities of phagocytes

Journal of Pharmacy and Pharmacology

Volumn 64, Issue 3, 2012, Pages 404-412

  Jantan, Ibrahim ^a   Bukhari, Syed Nasir Abbas ^a   Lajis, Nordin Haji ^b   Abas, Faridah ^b   Wai, Lam Kok ^a   Jasamai, Malina ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

chemiluminescence; chemotactic activity; curcumin diarylpentanoid analogues; immunomodulatory; polymorphonuclear leukocytes

Indexed keywords

1,5 BIS(2 FLUORO 4 METHOXYPHENYL) 1,4 PENTADIENE 3 ONE; 1,5 BIS(2,5 DIMETHOXYBENZYLIDENE)CYCLOHEXANONE; 1,5 BIS(2,5 DIMETHOXYPHENYL) 1,4 PENTADIENE 3 ONE; 1,5 BIS(2,6 DIMETHOXYPHENYL) 1,4 PENTADIENE 3 ONE; 1,5 BIS(3 CHLOROBENZYLIDENE)CYCLOHEXANONE; 1,5 BIS(3,4,5 TRIMETHOXYBENZYLIDENE)CYCLOHEXANONE; 1,5 BIS(4 FLUOROBENZYLIDENE)CYCLOHEXANONE; 2,6 BIS(2 CHLOROBENZYLIDENE)CYCLOHEXANONE; CURCUMIN; DIARYLPENTANOID DERIVATIVE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; IMMUNOMODULATING AGENT; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHEMOLUMINESCENCE; CHLORINATION; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; FLUORINATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; INNATE IMMUNITY; LEUKOCYTE MIGRATION INHIBITION; NEUTROPHIL CHEMOTAXIS; NORMAL HUMAN; PHAGOCYTE; RESPIRATORY BURST; STRUCTURE ACTIVITY RELATION;

ANTI-INFLAMMATORY AGENTS; CHEMOTAXIS; CURCUMIN; HUMANS; LUMINESCENCE; LUMINESCENT MEASUREMENTS; NEUTROPHILS; PHAGOCYTES; REACTIVE OXYGEN SPECIES; RESPIRATORY BURST;

EID: 84857059699     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01423.x     Document Type: Article

References (31)

1. Beutler B,. Innate immunity: an overview. Mol Immunol 2004; 40: 845-859. (Pubitemid 38035204)
2. Stephens L, et al,. Moving towards a better understanding of chemotaxis. Curr Biol 2008; 18: 485-494.
3. Eeden SF, et al,. The use of flow cytometry to measure neutrophil function. J Immunol Methods 1999; 232: 23-43. (Pubitemid 30017763)
4. Nagahata H, et al,. Analysis of the functional characteristics of L-selectin and its expression on normal and CD18-deficient bovine neutrophils. Immunol Cell Biol 2000; 78: 264-271. (Pubitemid 30415463)
5. Arnhold J,. Free radicals-friends or foes? Properties, functions and secretion of human myeloperoxidase. Biochem 2004; 69: 4-9.
6. Hougee S, et al,. Oral administration of the NADPH-oxidase inhibitor apocynin partially restores diminished cartilage proteoglycan synthesis and reduces inflammation in mice. Eur J Pharmacol 2006; 531: 264-269. (Pubitemid 43202245)
7. Itokawa H, et al,. Recent advances in the investigation of curcuminoids. Chin Med 2008; 3: 1-11.
8. Gupta SC, et al,. Multitargeting by curcumin as revealed by molecular interaction studies. Nat Prod Rep 2011; DOI: 10.1039/c1np00051a.
9. Kohli K, et al,. Curcumin; a natural anti-inflammatory agent. Indian J Pharmacol 2005; 37: 141-147.
10. Shakibaei M, et al,. Suppression of NF-kB activation by curcumin leads to inhibition of expression of cyclooxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes; Implications for the treatment of osteoarthritis. Biochem Pharmacol 2007; 73: 1434-1445. (Pubitemid 46452591)
11. Aggarwal BB, Sung B,. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 2009; 30: 85-94.
12. Aggarwal BB, et al,. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003; 23: 363-398. (Pubitemid 36361976)
13. Allam G,. Immunomodulatory effects of curcumin treatment on murine chistosomiasis mansoni. Immunobiology 2009; 214: 712-727.
14. Gupta SC, et al,. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 2010; 29: 405-434.
15. Anand P, et al,. Bioavailability of curcumin: problems and promises. Mol Pharmacol 2007; 4: 807-818.
16. 2+-dependent dioxygenase dke1. J Am Chem Soc 2005; 127: 12306-12314. (Pubitemid 41279254)
17. Liang G, et al,. Synthesis, crystal structure and anti-inflammatory properties of curcumin analogues. Eur J Med Chem 2009; 44: 915-919.
18. Fuchs JR, et al,. Structure-activity relationship studies of curcumin analogues. Bioorg Med Chem Lett 2009; 19: 2065-2069.
19. Park SK, et al,. Synthesis of substituted triazolyl curcumin mimics that inhibit RANKL-induced osteoclastogenesis. Bioorg Med Chem Lett 2011; 21: 3573-3577.
20. Lee KH, et al,. Synthesis and biological evaluation of curcumin-like diarylpentanoid analogues for anti-inflammatory, antioxidant and anti-tyrosinase activities. Eur J Med Chem 2009; 44: 3195-3200.
21. Parvathy KS, et al,. Antioxidant, antimutagenic and antibacterial activities of curcumin-β-diglucoside. Food Chem 2009; 115: 265-271.
22. Lam KW, et al,. Synthesis and evaluation of DPPH and anti-inflammatory activities of 2,6-bisbenzylidenecyclohexanone and pyrazoline derivatives. Med Chem Res DOI 10.1007/s00044-010-9521-0.
23. Tham CL, et al,. A synthetic curcuminoid derivative inhibits nitric oxide and proinflammatory cytokine synthesis. Eur J Pharmacol 2010; 628: 247-254.
24. Koko WS, et al,. In vitro immunomodulating properties of selected Sudanese medicinal plants. J Ethnopharmacol 2008; 118: 26-34.
25. Jantan I, et al,. Inhibition of chemiluminescence and chemotactic activity of phagocytes in vitro by the extracts of selected medicinal plants. J Nat Med 2011; 65: 400-405.
26. Magrisso MJ, et al,. Model components of luminol chemiluminescence generated by PMNL. J Biochem Biophys Methods 1995; 30: 257-269.
27. Sacerdote P, et al,. In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors. J Neuroimmunol 2000; 109: 155-163.
28. Parij N, et al,. Effects on non-steroidal anti-inflammatory drugs on the luminol and lucigenin chemiluminescence of human neutrophiles. Eur J Pharmacol 1998; 352: 299-305. (Pubitemid 28345130)
29. Kao HH, et al,. Structure-activity relationship studies on chalcone derivatives: the potent inhibition of chemical mediators release. Bioorg Med Chem 2003; 11: 105-111.
30. Rojas J, et al,. Synthesis and inhibitory activity of dimethylamino-chalcone derivatives on the induction of nitric oxide synthase. Eur J Med Chem 2002; 37: 699-705. (Pubitemid 34874903)
31. Spisani S, et al,. Inhibition of human leukocytes locomotion by anti-inflammatory drugs. Specialia 1978; 1: 803-804.